Bone aspect in long-standing liver and kidney diseases, part of physiology and clinical aspects

Interest in focused treatments for different types of osteoporosis has increased as a result of growing awareness of the liver, kidney, and bone interaction. Injury to the liver and kidneys caused by various disorders can disrupt bone metabolism, suggesting a new regulatory relationship among the liver, kidneys, and bones. But little is known about how the liver-bone center contributes to primary and secondary osteoporosis. Thus, investigating the precise regulatory motion of the liver-bone center may provide new curative strategies for the treatment of liver and bone disorders. Chronic liver disease is a prevalent health issue worldwide, especially in East Asia. Osteoporosis (OP), a prevalent metabolic bone disorder, has garnered heightened attention in ageing populations. In recent years, a growing association between osteoporosis and chronic kidney disease (CKD), belonging to the larger category of CKD-mineral and bone disease (CKD-MBD), has been noted. Changes in parathyroid hormone (PTH), vitamin D, calcium, and phosphorus metabolism are characteristics of CKD-MBD, which greatly increases the risk of fracture. This review aims to examine the correlation between chronic renal and liver illness and their effects on bone throughout the patient's lifespan.